I am a clinician | Zhang Jinying: There are about 670,000 atrial fibrillation patients in Henan, and it is very urgent to set up a Henan Provincial Atrial Fibrillation Prevention and Treatment Center!

Atrial fibrillation, short for atrial fibrillation, is a relatively common clinical tachyarrhythmia. In layman’s terms, the heart often beats wildly without special stimulation.

The biggest risk of atrial fibrillation is stroke, also known as cerebral infarction.

Because atrial fibrillation has insidious onset, There are no obvious symptoms and other characteristics, and the public does not have enough understanding of its hazards. This has resulted in a low treatment rate for atrial fibrillation and a grim prevention and control situation.

about 670,000 houses in Henan Only 1% of patients with fibrillation have received radiofrequency ablation, and it is very urgent to establish a Henan Provincial Atrial Fibrillation Prevention and Treatment Center

< /span>

At present, the overall prevalence of atrial fibrillation in my country ranges from 5‰ to 7‰. According to the 2021 census of 1,411.78 million people nationwide, there are 9.88 million atrial fibrillation patients in my country. Calculated based on the population of 96.05 million in Henan, there are about 670,000 atrial fibrillation patients in Henan.

2021, published in Heart Magazine A related epidemiological survey in China found that in my country, the awareness rate of atrial fibrillation is low. More than one-third of people aged 45 to 54 years old and nearly half of people with atrial fibrillation in people over 75 years old do not know they have atrial fibrillation.

2021, radiofrequency ablation of atrial fibrillation in my country A total of 100,000 surgeries were performed. For patients who actively seek medical treatment and receive anticoagulant and antiarrhythmic drug treatment, studies have shown that the treatment rates in China’s top three hospitals and non-tertiary hospitals are 29.12 % and 11.44 %, respectively. About 1% of all patients with atrial fibrillation undergo radiofrequency ablation.

“Currently, as our country ages, The aggravation of atrial fibrillation, the change of people’s living environment and lifestyle, and the combined effect of bad living habits and other factors, the prevalence of atrial fibrillation is getting higher and higher.”The First Affiliated Hospital of Zhengzhou University Zhang Jinying, director of the Department of Cardiology, said that as the head of the Henan Interventional Center for Arrhythmia and Atrial Fibrillation, he found in clinical and research that a large number of patients with atrial fibrillation are in the community or rural areas, and it is common The awareness rate of hypertension is low, and the lack of talents in grass-roots hospitals and the lack of prevention and treatment level lead to a low treatment rate, and the prevention and treatment of atrial fibrillation is imminent.

track=”10″>Currently, there are three main ways to treat atrial fibrillation.

1. Medication: need to be taken for life With frequent monitoring, there may be risk of bleeding and suboptimal control.

2. Surgical treatment: mainly Minimally invasive labyrinth surgery has a higher success rate but slightly more trauma than catheter ablation.

3. Catheter radiofrequency ablation: domestic It has been carried out for more than 20 years, and it is relatively mature. It does not require surgery, only 3 to 4 needles are needed, and the success rate is high, which can reach 90% or even higher, but it needs to be operated in an experienced hospital.

“” The effect of the operation is the best and the trauma is the least.” Zhang Jinying said that after the acute phase of the stroke, the patients with atrial fibrillation who have suffered a stroke and their body language and other functions have recovered well, receiving radiofrequency ablation therapy has a certain positive significance and helps prevent recurrence. . However, the stroke has already occurred, and the pain and burden brought to the patient and family are irreversible in the later stage of catheter radiofrequency ablation. Therefore, it is strongly recommended that atrial fibrillation should be treated aggressively as soon as possible after diagnosis.

” Popularize the knowledge of atrial fibrillation prevention and treatment to all communities and the most grass-roots medical personnel in the province, so that more grass-roots It is the key to the prevention and treatment of atrial fibrillation that patients receive standardized treatment.” Zhang Jinying said, relying on the administrative executive power of government departments, combined with the characteristics of the incidence of atrial fibrillation in our province, it is very urgent to establish a center for the prevention and treatment of atrial fibrillation in Henan Province. The solution is to improve the overall level of atrial fibrillation prevention and treatment.

Men often suffer from palpitations and chest tightness , 5 coronary angiograms were performed, but no organic lesions were found

strong>

Zhang Jinying once treated a man in his 30s.The man was under great work and mental pressure, and often worked overtime until late at night. Before seeing the doctor, he often had palpitations, suffocation in the precordial area, tingling pain and discomfort, dizziness, headache, insomnia, difficulty concentrating, and was often restless, thinking that he had suffered from heart disease.

” However, ECG, Holter, He did both CT and MRI, and even did 5 coronary angiograms, but no organic lesions were found.” Zhang Jinying said that the man mainly had psychological problems, because he had a heavy mental burden and was physically weak. Overdraft causes endocrine disorder, the sympathetic nervous system is highly excited, and a series of symptoms such as palpitations, restlessness, insomnia and rapid heart rate are caused by anxiety.

Morning clinic reception Of the 70 people, there are about a dozen people with mental disorders.” Zhang Jinying said that this situation is called “double heart disease”, also known as double heart medicine or psychocardiology, which belongs to the category of “psychosomatic medicine” and is a kind of A new discipline formed by the intersection and synthesis of cardiovascular and psychological medicine. However, the awareness rate of “double heart disease” among the general public and medical staff is very low, which leads to a high rate of missed diagnosis and misdiagnosis, and naturally it is impossible to talk about correct treatment.

“The incidence of cardiovascular disease is increasing High, many data show that the occurrence of cardiovascular disease has a great relationship with the usual bad habits and negative emotions.” Zhang Jinying said that long-term anger, sadness, loneliness, stress and other emotions will increase cardiovascular disease. incidence and increased mortality from heart disease. For example, due to excessive sadness and fear, the body may release a large amount of catecholamines in an instant, resulting in death from ventricular tachycardia and ventricular fibrillation.

pH1g/6″ width img>

“So, everyone In life, you must learn to relax yourself, keep your mind calm, and learn to be content and happy, and you should put aside all psychological burdens to face life and work, so that you can have a healthy body.” Zhang Jinying said, at the same time, it is necessary to strengthen continuing medicine Education and continuous improvement of doctors’ awareness of mental and psychological disorders and double-heart diseases are essential. It is necessary to strengthen public health education and improve the cognition of “double-heart diseases” in order to obtain the curative effect of treating the disease and getting twice the result with half the effort.

University Affiliated Hospital doctors need to balance clinical and scientific research

p>

Henan Province is a province with a large population and a high incidence of cardiovascular disease. Now the number of people suffering from various types of heart disease in the province is 12-16 million, and the mortality rate is as high as 118.90 /100,000. cardiovascular causes the second-highest number of deaths in the country. Cardiovascular diseases seriously affect the quality of life and life expectancy of the people in the province.

Zhang Jinying said that the cause of this phenomenon is The main reason is that we have not controlled many risk factors, such as hypertension, hyperglycemia, hyperlipidemia, smoking, etc., cardiovascular causes cannot be effectively controlled, and people’s living habits cannot be improved quickly. Treatment compliance is not high.

We as a medical worker We must care about the patient, and we must continuously improve the ability and level of treatment.” Zhang Jinying said that compared with the past, the spectrum of cardiovascular diseases has undergone fundamental changes, such as arrhythmia, heart failure, coronary heart disease, and congenital heart disease. , hypertrophic cardiomyopathy, hypertension, pulmonary embolism and degenerative heart valve disease have become common and frequent diseases. Therefore, a very important task for us in the future is to base ourselves on the Central Plains, actively study the diagnosis and treatment of common diseases, frequently-occurring diseases, and complex, difficult and critical cardiovascular diseases, and find out the data on the incidence and mortality of cardiovascular diseases.

” Second, the search for new technologies and new methods.” Zhang Jinying said that both in the field of non-invasive treatment and in the field of invasive treatment, there is currently a lack of new technologies and new methods of their own. Therefore, it is necessary to intensify the exploration of new technologies and new methods, which requires clinicians to pay more attention to scientific research, and doctors in the affiliated hospital of the university need to take into account both clinical and scientific research.

Cardiovascular Medicine is one of the key disciplines of the First Affiliated Hospital of Zhengzhou University, and has made important progress and improvement in recent years.

Currently, cardiovascular medicine, regardless of the basic Both research and clinical medicine are in a period of rapid development. He has carried out a series of industry-leading projects and technologies, such as interventional treatment of complex coronary heart disease, including rotational atherectomy and laser ablation of calcified lesions, and precise coronary therapy guided by intraluminal imaging combined with vascular functional evaluation. In the treatment of arrhythmia, new technologies such as leadless pacemaker implantation and cryoballoon ablation of atrial fibrillation are carried out. In structural heart disease, advanced technologies such as percutaneous aortic valve replacement and Mitraclip have also been carried out.

track=”28″>In addition, the Department of Cardiovascular Medicine of the First Affiliated Hospital of Zhengzhou University established the first platform for the research and prevention of genetic cardiovascular diseases in China; presided over the completion of the Henan Province Heart Failure Cohort Study (National “Thirteenth Five-Year Plan”) “Prevention and Control of Major Chronic Diseases), conducted in-depth research on the current status of heart failure treatment in hospitals at all levels in Henan Province, and obtained comprehensive and detailed first-hand information, which provided a basis for rational and standardized treatment of heart failure in Henan Province and even the whole country. It lays a foundation for further strengthening the in-hospital and out-of-hospital management of heart failure patients in the future. Guided by the promotion of in-depth cooperation between industry, academia and research and the transformation of achievements, the research and development of atrial fibrillation catheter ablation simulator under the guidance of the three-dimensional mapping system (National High-tech Research and Development Program, “11th Five-Year” 863 Plan) and cardiac three-dimensional mapping are completed. Research and development of measurement system (national “Twelfth Five-Year” support project).

“Our goal is to cultivate a A large number of leading talents, innovative teams, academic leaders and young talents with international level. At the same time, we will build a national academic platform and undertake more original clinical research.” Zhang Jinying said.

Expert Business Card

MQibNsA/640″ width Zhang Jinying, chief physician, second-level professor, doctoral supervisor, and post-doctoral cooperative supervisor.

He is currently a cardiologist in the First Affiliated Hospital of Zhengzhou University Director of Department of Vascular Medicine, Director of Henan Provincial Cardiovascular Disease Clinical Medical Research Center, Director of Henan Provincial Key Laboratory of Heart Injury Repair, Director of Henan Provincial Heart Disease Research International Joint Laboratory, Director of Henan Provincial Cardiovascular Disease Research Medical Key Laboratory, Zhengzhou University Director of Cardiovascular Disease Prevention Research Center of Advanced Medical Research Center, etc.

Mainly engaged in the pathogenesis of cardiovascular disease and Prevention and treatment research, familiar familiar with the diagnosis and treatment of common diseases, frequently-occurring diseases and difficult and critical diseases in cardiovascular medicine, and is good at coronary heart disease stent placement, rapid Arrhythmia radiofrequency ablation, pacemaker and CRT-D implantation, cardiac valve stenosis balloon dilation and congenital heart disease closure and other interventional diagnosis and treatment technologies.

Presided over the national diagnosis and treatment of difficult cardiovascular and cerebrovascular diseases Capacity Improvement Project, National Key R&D Program, National Natural Science Foundation-Joint Fund Key Projects and General Projects, China Postdoctoral Science Foundation, Henan Province Science and Technology Innovation Outstanding Youth/Outstanding Talent Program, Henan Province University Science and Technology Innovation Team, and Henan Province Medical Science and Technology The key projects are jointly built by the province and the ministry.

Published more than 100 papers, some research The results have been published in top international journals such as “European Heart Journal”, “Nature Reviews Cardiology”, “Circulation Research”, “Nature Communication”, “Arterioscler Thromb Vasc Biol” and “Biomaterials”. Editor-in-chief of 6 books including “Modern Treatment Strategies of Acute Myocardial Infarction” and “New Progress in Post-PCI Risk Assessment of Coronary Heart Disease”, and served as “Journal of Clinical Cardiovascular Diseases”, “China Research Hospital”, “Journal of Zhengzhou University (Medical Edition)” “Editorial Committee, etc.

The first finisher was awarded Henan Science and Technology 1 first prize of the Progress Award, 3 second prizes of the Henan Provincial Science and Technology Progress Award and 1 second prize of the Henan Provincial Natural Science Award.

Won the high-level talents in Henan Province, the leading talents in the Central Plains, the academic and technical leaders in Henan Province, the model of medical ethics and medical style in Henan Province, the outstanding doctors in Henan Province, the Distinguished Professor of Zhengzhou University, and the Zhengzhou University The title of Sanyuren Advanced Individual and so on.

Concurrently serving as a member of the China Research Hospital Association for Heart Failure Chairman of the Professional Committee, Standing Committee Member of the ECG and Cardiac Function Branch of the Chinese Geriatrics Association, Executive Director of the 11th Council of the Henan Medical Association, President of the Cardiovascular Medicine Branch of the Henan Medical Association, and Cardiovascular Disease of the Henan Medical Association Vice-Chairman of the Academic Division, etc.